Kilroy Realty(KRC) - 2025 Q3 - Earnings Call Transcript

Financial Data and Key Metrics Changes - FFO for the quarter was $1.08 per diluted share, including approximately $0.03 per share of one-time items [21] - Cash same property NOI growth for the third quarter was 60 basis points, with real estate tax appeals contributing to 150 basis points of growth [21] - Occupancy improved modestly, ending at 81%, up from 80.8% at the end of the second quarter [21] Business Line Data and Key Metrics Changes - Over 550,000 sq ft of new and renewal leases were signed during the quarter, marking the highest third quarter of leasing activity in six years [5] - In San Francisco, office demand reached a post-pandemic high of nearly 9 million sq ft, up from approximately 7 million sq ft last quarter [5] - Life science demand rose over 20% from 1.8 million sq ft to 2 million sq ft in Q3 [40] Market Data and Key Metrics Changes - San Francisco led all U.S. metros in office leasing growth over the last 12 months [5] - Tour activity in SoMa assets increased by 170% year-over-year [6] - The XBI index is up more than 20% year to date, indicating strong performance in the biotech sector [9] Company Strategy and Development Direction - The company is focusing on capturing growing demand across its markets and ensuring assets are well-positioned to outperform [8] - The acquisition of Maple Plaza in Beverly Hills marks the company's first investment in a highly sought-after area with low vacancy rates [12] - The Flower Mart Project is being redesigned with multiple development scenarios submitted to the city's planning department [14] Management's Comments on Operating Environment and Future Outlook - Management noted that the return to office is improving, driven by evolving workplace norms and recognition of the office's role in culture and collaboration [4] - The company anticipates modest improvement in occupancy in the fourth quarter due to accelerated rent commencement activity [22] - Management raised the 2025 FFO outlook to a range of $4.18-$4.24 per share, reflecting positive updates to expectations [23] Other Important Information - The company completed the sale of a four-building campus in Silicon Valley for gross proceeds of $365 million [12] - The company is actively engaged with potential tenants for KOP 2, with discussions reflecting an overall improvement in the life science market [11] - The company is focused on optimizing portfolio returns and maintaining a strong capital structure [13] Q&A Session Summary Question: Thoughts on retention for expirations and occupancy commencement - Management indicated that the remaining expiration pool for 2026 is about 970,000 sq ft, with limited opportunities for additional renewals [30][31] Question: Competitive positioning in San Francisco - Management noted a shift in tenant preferences towards landlords who can deliver space quickly, with significant demand from AI companies [34][36] Question: Update on KOP leasing activity and demand - Management reported strong demand across various sectors, including biotech, AI, and robotics, with a focus on creating a dynamic life science ecosystem [40][42] Question: Insights on NeueHouse lease and rent contribution - Management clarified that the departure of NeueHouse will impact occupancy but the space's high-quality build-out is generating strong interest from prospective users [48][49] Question: Lease economics at KOP - Management stated that lease economics vary, but rental rates are holding steady relative to original underwriting, with higher tenant improvement costs [52][53] Question: Capital allocation strategy and priorities - Management emphasized a disciplined approach to capital allocation, evaluating opportunities for investment and maintaining a strong balance sheet [78][80]